1994
DOI: 10.1111/j.1600-0714.1994.tb00054.x
|View full text |Cite
|
Sign up to set email alerts
|

Effects of nicotine and tobacco‐specific nitrosamines on hamster cheek pouch and gastric mucosa

Abstract: Fifty-two hamsters were divided into 6 groups and their cheek pouches treated with either 0.01% NNN, 0.01% NNN and 6% nicotine, 0.01% NNK, 0.01% NNK and 6% nicotine, 6% nicotine, or sesame oil. After painting each pouch 3 times per week for 13 months, the animals were killed and specimens from the cheek pouch and forestomach examined. Cheek pouch epithelium showed more frequent histologic changes, including hyperplasia, hyperkeratosis and, in one animal, moderate dysplasia, when nicotine was combined with NNN … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
22
0

Year Published

2001
2001
2024
2024

Publication Types

Select...
4
3
1

Relationship

0
8

Authors

Journals

citations
Cited by 22 publications
(22 citation statements)
references
References 18 publications
0
22
0
Order By: Relevance
“…Predominant nicotine effects consist of: increase in heart rate and cardiac contractility (Franco-Cereceda et al, 1991;Benowitz et al, 2002;Pausova et al, 2003), increase in the blood pressure (Pausova et al; Ochiai et al), reduction of temperature skin (Plowchalk et al;Russell et al, 2004) and mobilization of the sugar in the blood (Gilbert et al, 2000). Reports about In vitro results shown: increase in the hormones synthesis and release (Seaman et al, 1977;Damaj, 2001;Wessler et al, 2003), activation of ERK (Chen et al, 1994;Szajerka & Kwiatkowska, 1997) and transcription nuclear factors (inflammatory factors as NFkB and AP-1) (Pennypacker et al; Pandey et al; Ueno et al), production of shock proteins Fig. 5.…”
Section: Discussionmentioning
confidence: 99%
“…Predominant nicotine effects consist of: increase in heart rate and cardiac contractility (Franco-Cereceda et al, 1991;Benowitz et al, 2002;Pausova et al, 2003), increase in the blood pressure (Pausova et al; Ochiai et al), reduction of temperature skin (Plowchalk et al;Russell et al, 2004) and mobilization of the sugar in the blood (Gilbert et al, 2000). Reports about In vitro results shown: increase in the hormones synthesis and release (Seaman et al, 1977;Damaj, 2001;Wessler et al, 2003), activation of ERK (Chen et al, 1994;Szajerka & Kwiatkowska, 1997) and transcription nuclear factors (inflammatory factors as NFkB and AP-1) (Pennypacker et al; Pandey et al; Ueno et al), production of shock proteins Fig. 5.…”
Section: Discussionmentioning
confidence: 99%
“…12, p. 1653, 2001 Copyright © 2001 1653 growth, motility, and differentiation (Heeschen et al, 2001). Although it has been reported that Nic directly affects OKC (Chen et al, 1994;Hall et al, 1984;Ringdahl et al, 1997), the kind of cellular alterations and the biochemical pathways mediating the effect of Nic remain unclear. Simultaneous exposure to Nic and hyperoxia causes tumors in hamsters, and antagonists of nAChRs inhibit this process (Schuller et al, 1995).…”
Section: Discussionmentioning
confidence: 99%
“…Nic, acting through the nAChRs expressed by nonneuronal cells, has recently emerged as a candidate for the major pathogenic factor in tobacco-related morbidity because it exhibits a regulatory role in the biological processes which are intimately connected with each other, including cell growth, motility, and differentiation (Heeschen et al, 2001). Although it has been reported that Nic directly affects OKC (Chen et al, 1994;Hall et al, 1984;Ringdahl et al, 1997), the kind of cellular alterations and the biochemical pathways mediating the effect of Nic remain unclear. Simultaneous exposure to Nic and hyperoxia causes tumors in hamsters, and antagonists of nAChRs inhibit this process (Schuller et al, 1995).…”
mentioning
confidence: 99%
“…3 It has also been reported that frequent nicotine exposure caused hyperkeratosis in the hamster cheek pouch. 4 NiQuitin CQ® Lozenges are NRT loz enges that come in 2 mg and 4 mg for mulations. They are kept in the mouth for up to 30 minutes and patients are instructed to take one lozenge every one to two hours, up to a maximum of 15 lozenges per day for six weeks.…”
Section: Discussionmentioning
confidence: 99%